BEAT News and Press, Heartbeam Inc. From 03/08/23

Robert Eno Assumes Duties of Chief Business Officer Jon Hunt to Remain Strategic Advisor & Consultant to HeartBeam HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart att...

During interview, Vajdic recounts first steps of journey in the United States CEO points to key lessons he learned that helped him found HeartBeam The company has developed the first and only 3D-vector 12-lead electrocardiogram (“ECG”) platform for heart attack detection anytim...

HeartBeam (NASDAQ: BEAT) , a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (“VECG”) platform for heart attack detection anytime, anywhere, today announced its plans to host a conference call to discuss its results for the fourth quarter...

HeartBeam, Inc . (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack detection anytime, anywhere, will hold a conference call on Thursday March 16, 2023 at 4:30 p.m. Eastern time to discuss its results f...

President Biden proclaims February as American Heart Month Annual tradition provides opportunity to focus on nationwide problem of heart and blood-vessel diseases HeartBeam is committed to being part of the solution for identifying, treating heart attacks Following a decades-long tradition...

HeartBeam (NASDAQ: BEAT) is a cardiac technology company that is leading the way in identifying heart attacks by developing a personal, portable and easy-to-use heart-attack detection solution. “The company has two patented products in development: HeartBeam AIMI(TM), software for acute c...

Summary The company's products, HeartBeam AIMI and HeartBeam AIMIGo, are being developed with the aim of providing accurate diagnostic tools for heart attack detection anytime and anywhere. The core technology is protected by a strong and expanding IP portfolio comprising multiple paten...

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (“VECG”) platform for heart attack detection anytime, anywhere, has appointed Robert Eno to the newly created position of president. A senior medical technology ...

HeartBeam ( NASDAQ: BEAT ) has announced the appointment of Robert Eno to the newly created position of President. Eno has a proven track record of developing markets and commercializing disruptive medical technologies. He will play a key role in the strategic direction, ...

Senior Medical Technology Executive to Enhance Company’s Strategic and Operations Capabilities HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack detection anytime, an...